Literature DB >> 32588215

Extranodal NK/T Cell Lymphoma, Nasal Type with Palatal Involvement: A Rare Case Report and Literature Review.

Anastasia Andreou1, Grigorios Thermos2, Alexandra Sklavounou-Andrikopoulou1.   

Abstract

T-cell lymphomas are infrequently encountered in the head and neck area, with the most common subtype being Extranodal NK/T cell lymphoma, nasal type (ENKTL-NT). ENKTL-NT shows a predilection for midline facial structures presenting with ulcerative destructive lesions, whereas palatal involvement is one of the most prominent signs from the oral cavity. Herein, we describe a case of a 76-year-old Greek man with nasal obstruction and an extensive painful necrotic ulcer with ragged borders on the left distal portion of the soft palate and palatine tonsil of 4-months duration. After an initial non-diagnostic biopsy from the nasopharynx, a second incisional biopsy from the palatal lesions was performed. Histopathology was suggestive of an angiocentric lymphoproliferative neoplasm and immunohistochemical examination and in situ hybridization for EBV RNA led to a final diagnosis of ENKTL-NT. The patient was placed under combined chemotherapy and radiotherapy and no recurrence has been noted. Additionally, a retrospective review of the cases in the English literature with an established diagnosis of ENTKL-NT between 2000 and 2019, based on the latest WHO classification of Head and Neck tumors, is performed.

Entities:  

Keywords:  EBV; Extranodal NK T cell; Lymphoma; Oral cavity; Palate; Ulcer

Mesh:

Year:  2020        PMID: 32588215      PMCID: PMC8134638          DOI: 10.1007/s12105-020-01182-8

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  35 in total

1.  Nasal T/NK cell lymphoma: report of 3 cases involving the palate.

Authors:  W M Tsang; A C Tong; K Y Lam; H Tideman
Journal:  J Oral Maxillofac Surg       Date:  2000-11       Impact factor: 1.895

2.  NK/T Cell Lymphoma: A Tertiary Centre Experience.

Authors:  Neeraj Arora; Arpan Mehta; Sriram Ravichandran; Indu Arun; Rimpa Basu Achari; Anupam Chakrapani; Saurabh Jayant Bhave; Mammen Chandy; Reena Nair
Journal:  Indian J Hematol Blood Transfus       Date:  2016-04-21       Impact factor: 0.900

3.  Palatal ulcerations and midfacial swelling.

Authors:  Graziella Chagas Jaguar; Danyel Elias da Cruz Perez; Vladmir Cordeiro de Lima; Antônio Hugo Campos; Fábio Abreu Alves
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-10

4.  Nasal NK/T-cell lymphoma: A tragic case.

Authors:  L Taali; M Abou-Elfadl; M Fassih; M Mahtar
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2016-10-24       Impact factor: 2.080

5.  Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.

Authors:  Tae Min Kim; Yeon Hee Park; Sang-Yoon Lee; Ji-Hoon Kim; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Chul Woo Kim; Dae Seog Heo; Yung-Jue Bang; Kee-Hyun Chang; Noe Kyeong Kim
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

Review 6.  An unusual presentation of NK/T-cell lymphoma, nasal-type in the United States.

Authors:  Sarah M Kidwai; Arjun K Parasher; Fred Y Lin
Journal:  Am J Otolaryngol       Date:  2014-07-24       Impact factor: 1.808

7.  PET/CT aids the staging of and radiotherapy planning for early-stage extranodal natural killer/T-cell lymphoma, nasal type: a case series.

Authors:  Shannon L MacDonald; Liam Mulroy; Derek R Wilke; Steven Burrell
Journal:  Radiat Oncol       Date:  2011-12-30       Impact factor: 3.481

8.  Oral and maxillofacial non-Hodgkin lymphomas: Case report with review of literature.

Authors:  Da Deng; Ying Wang; Weisong Liu; Yong Qian
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

Review 9.  The diagnosis and management of NK/T-cell lymphomas.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  J Hematol Oncol       Date:  2017-04-14       Impact factor: 17.388

Review 10.  Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress.

Authors:  Yasuaki Harabuchi; Miki Takahara; Kan Kishibe; Toshihiro Nagato; Takumi Kumai
Journal:  Front Pediatr       Date:  2019-04-16       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.